Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

Had they included just one of Tony Hoare’s achievements, many scientific careers would be considered prestigious enough. His had a long list, unfortunately closed by his passing away at the age of 92 ...

Recursion Pharmaceuticals, Inc ( (RXRX)) has held its Q4 earnings call. Read on for the main highlights of the call.

Costumed beasts and creepy crawlies aren’t limited to Halloween. This week a wild and woolly band of bloodthirsty space ...

In the last few years, Chinese AI startup MiniMax has become one of the most exciting in the crowded global AI marketplace, ...

Director Corey Andrew Barr explains why the upcoming edition will be the fair’s boldest, most forward-looking chapter yet.

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Balancing nitrogen use is critical for maximizing crop yield while minimizing environmental and economic costs. A new approach integrates drone-based multispectral imaging with machine learning to ...

The judge said he didn't follow the correct procedure for what is effectively a move to deny patients care.